The Mini-Gastric Bypass

       

Studies show the MGB is More Effective than the LAP-BAND®* / Safer than the RNY Gastric Bypass**

 

Bypass Arthritis

 
 
Home Up Patient Emails Search Contents Contact Us Compare MGB
 

Mini-Gastric Bypass

   

Las Vegas, Nevada Dr. Rutledge
Email: DrR@clos.net or
Call Talk to Dr. Rutledge Now at: 702-215-9550
Free

Orlando, Florida  Dr. Peraglie

Email: DrP@clos.net or
Call Dr. Peraglie Now at: 407-922-3424
Free

   

MGB Cures Diabetes?

 

Start Here

Get Our
Patient Manual

Join Our
Mailing List

Patient
Application
Form

MGB
Animation

Watch 100s
of Videos

Got Lap-Band
Problems?

How Much
Does it Cost

Search

Mailing List

Pictures

MGB Papers

Daily Emails

PreOp
Process

MGB Manual

Meet Our
Patients

Patient
Application

Patient Letter

MGB Video

Our Brochure

Search

Follow Up

MGB vs RNY

Research

Take Survey

Discharge
Instructions

Home
Up

14 citations found

Other Formats: [Citation Format] [MEDLINE Format]
Links: [105 medline neighbors]
Order this document
Clin Rheumatol 1991 Dec;10(4):449-51

Post biliopancreatic bypass arthritis. Dermatitis syndrome.

Cantatore FP, Carrozzo M, Loperfido MC

Department of Rheumatology, University of Bari, Italy.
A case of arthritis dermatitis syndrome observed after a biliopancreatic bypass for morbid obesity is described. The syndrome had begun 10 days after surgery and involved the knees, ankles, elbows and wrists and erythema nodosum on the legs. After 15 days treatment with sulfasalazine and steroid the symptoms disappeared. The immunologic aetiology of the disease was postulated and the observation of the syndrome, for the first time, after a biliopancreatic bypass suggested that the manifestation of the disease is independent of the kind of the surgical procedures used for the treatment of the morbid obesity.
PMID: 1686994, UI: 92200811
Other Formats: [Citation Format] [MEDLINE Format]
Links: [107 medline neighbors]
Order this document
Dig Dis Sci 1990 May;35(5):656-60

Cure of arthritis-dermatitis syndrome due to intestinal bypass by resection of nonfunctional segment of blind loop.

Drenick EJ, Roslyn JJ

Medical and Research Service, Wadsworth VA Medical Center, Los Angeles, California 90073.
Many complications that followed jejunoileal bypass operations performed for the relief of morbid obesity were caused by bacterial overgrowth in the excluded blind loop. The arthritis-dermatitis syndrome was one of the common distressing disorders. The pathogenetic mechanism was thought to be an immune-complex-mediated process related to bypass enteritis. Antiarthritic medication was ineffective in most instances, and the skin lesions were refractory to treatment. A 45-year-old woman was suffering from the disorder as described above. She also had diarrhea, a low hematocrit, an elevated white blood cell count, and an increased sedimentation rate. Her nutritional status was satisfactory, presumably because of adaptive hypertrophy of the short functioning small intestinal segment. The patient adamantly refused dismantling of the bypass or any gastric restriction operations. Therefore, the blind loop, the source of her disease, was excised with immediate relief of all ill effects and restoration of normal laboratory findings. The patient has been entirely well since, and her weight has remained stable for one year.
PMID: 2331958, UI: 90235725
Other Formats: [Citation Format] [MEDLINE Format]
Links: [119 medline neighbors]
Order this document
Baillieres Clin Rheumatol 1989 Aug;3(2):339-55

Jejunoileal bypass arthritis.

Ross CB, Scott HW, Pincus T

Although intestinal bypass procedures are no longer performed, important lessons have been learned concerning clinical arthritides resulting from bacterial overgrowth and immune complex deposition. This information is of considerable value in patients who present with the clinical picture of intestinal bypass arthritis on the basis of other bowel abnormalities. Furthermore, the pathogenetic mechanisms involving bacterial overgrowth, release of bacterial antigens, and immune complex deposition may be pertinent to many types of inflammatory arthritis.
Publication Types:
Review
Review, tutorial
PMID: 2670259, UI: 89354621
Other Formats: [Citation Format] [MEDLINE Format]
Links: [117 medline neighbors]
Order this document
Clin Exp Rheumatol 1987 Jul-Sep;5(3):275-87

Bypass disease.

Clarke J, Weiner SR, Bassett LW, Utsinger PD

Department of Rheumatology, Mount Sinai Hospital, Medical Center, Chicago, Illinois.
Intestinal bypass surgery as a treatment for morbid obesity was quite popular from 1965 to 1975 in the United States. The procedure was successful in reducing body weight but was controversial because of a high rate of complications which included an arthritis-dermatitis syndrome. Herein we review the knowledge garnered from a study of the complications from intestinal bypass surgery. Emphasis is placed on an analysis of the clinical manifestations, and the pathogenesis of the arthritis-dermatitis bypass syndrome, and how bypass disease may serve as a model for immune complex-mediated disease and for extra-intestinal complications in other enteropathies.
Publication Types:
Review
Review, academic
PMID: 3322621, UI: 88110135
Other Formats: [Citation Format] [MEDLINE Format]
Links: [144 medline neighbors]
Order this document
Tidsskr Nor Laegeforen 1986 Dec 10;106(34-36):2984

[Intestinal bypass dermatitis-arthritis syndrome. A rare complication in the surgical treatment of obesity].

[Article in Norwegian]

Jensen P

PMID: 3810622, UI: 87121096
Other Formats: [Citation Format] [MEDLINE Format]
Links: [138 medline neighbors]
Order this document
Arch Intern Med 1984 Apr;144(4):738-40

Bowel-associated dermatosis-arthritis syndrome. Immune complex-mediated vessel damage and increased neutrophil migration.

Jorizzo JL, Schmalstieg FC, Dinehart SM, Daniels JC, Cavallo T, Apisarnthanarax P, Rudloff HB, Gonzalez EB

In a recent report we described a syndrome, identical to bowel-bypass syndrome, that occurred in four patients who had not had bypass surgery. Herein, circulating immune complexes (CICs) and neutrophil migration are evaluated in three of those four patients to test the hypothesis that the cutaneous lesions might have resulted from interaction between immune complex-mediated vessel damage and increased neutrophil migration. In vitro assays indicated that CICs were present in one of two patients and "histamine trap" test evidence for CICs was present in both patients tested. Although serum from the three patients appeared to increase neutrophil movement, statistically significant increases were not observed when data were pooled in this small study group. Preliminary results suggest that immune complex-mediated vessel damage, followed by extensive accumulation of neutrophils, may cause the pustular vasculitis in the bowel-associated dermatosis-arthritis syndrome.
PMID: 6712372, UI: 84177692
Other Formats: [Citation Format] [MEDLINE Format]
Links: [175 medline neighbors]
Order this document
Rev Infect Dis 1984 Mar-Apr;6 Suppl 1:S80-4

Jejunoileal bypass: change in the flora of the small intestine and its clinical impact.

Corrodi P

Among the complications of jejunoileal bypass for morbid obesity are proctitis, bypass enteritis, liver disease, dermatitis, and arthritis, all of which are thought to be connected with the intestinal microflora. Quantitative cultures from the small bowel of patients before the establishment of the bypass and from patients with reoperations indicate colonization of both the functioning small bowel (bacterial counts, 10(5.0)-10(7.6)/ml) and of the bypassed loop (bacterial counts, 10(6.4)-10(9.7)/ml). Experiments in animals have shown that the presence of a bypassed loop, as compared with that of a resected bowel, is necessary for increased weight loss and for the development of liver disease. Clinical evidence for the impact of the intestinal microflora is based on the beneficial effect of antimicrobial agents, especially metronidazole, and on the demonstration of immunologic phenomena involving antigens of bacterial origin. Complications of jejunoileal bypass may serve to elucidate the pathogenesis of other diseases.
Publication Types:
Review
PMID: 6372041, UI: 84195884
Other Formats: [Citation Format] [MEDLINE Format]
Links: [135 medline neighbors]
Order this document
Acta Derm Venereol 1984;64(1):79-82

Bowel bypass arthritis dermatitis syndrome: a histological and electron microscopical study.

Sandbank M, Weltfriend S, Wolf R

A case of dermal vasculitis with arthralgia after intestinal bypass surgery is reported. A 36-year-old woman developed arthralgia and skin rash, 1 year after an ileo-jejunal bypass operation was performed for overweight (130 kg). Skin biopsy showed leucocytoclastic vasculitis in the dermis. E.M. study showed clumps of platelets around small dermis blood vessels, and polymorphous perivascular infiltration. The symptoms subsided after tetracycline treatment.
PMID: 6203290, UI: 84226885
Other Formats: [Citation Format] [MEDLINE Format]
Links: [138 medline neighbors]
Order this document
J Rheumatol 1983 Aug;10(4):612-8

A prospective analysis of the arthritis syndrome and immune function in jejunoileal bypass patients.

Leff RD, Towles W, Aldo-Benson MA, Madura J, Biegel AA

Fifty-two patients undergoing jejunoileal bypass surgery were prospectively evaluated to determine: 1) the incidence of the associated arthritic syndrome; 2) whether we could identify patients at risk for arthritis prior to surgery; and 3) changes in immune function. The incidence of arthritis was 28% and was frequently associated with dermatitis. No preoperative clinical or laboratory parameters identified those patients at risk to develop rheumatic problems. Circulating immune complexes were found in both arthritis and non-arthritis patients after surgery. Mean serum levels of IgA rose significantly after surgery only in patients who developed arthritis, but remained within the normal range. No other immunologic abnormalities were noted.
PMID: 6620263, UI: 84010661
Other Formats: [Citation Format] [MEDLINE Format]
Links: [131 medline neighbors]
Order this document
Scand J Rheumatol 1983;12(3):257-9

Episodic arthritis, skin manifestations and immune complexes following intestinal by-pass operations for morbid obesity.

Heyn J, Hey H, Jans H, Baek L, Ullman S, Halberg P

A systematic search for immune complexes (IC) in blood and skin revealed no correlation to IC-related disorders in 35 patients who had undergone jejunoileal bypass for obesity. Tests for cryoprecipitates and endotoxins proved negative.
PMID: 6623014, UI: 84017453
Other Formats: [Citation Format] [MEDLINE Format]
Links: [124 medline neighbors]
Order this document
Arthritis Rheum 1981 May;24(5):684-90

The intestinal bypass: arthritis-dermatitis syndrome.

Stein HB, Schlappner OL, Boyko W, Gourlay RH, Reeve CE

Of the 31 patients who developed polyarthritis following jejunoileal bypass for obesity, 24 had cutaneous vasculitis (urticarial, pustular, and nodular), 11 paresthesias, 10 Raynaud's phenomenon, and 1 pericarditis. Blind loop symptoms (14 of 26 patients), cryoglobulinemia (10 of 28), and immune deposits in biopsied skin lesions (5 of 7) support the theory of a relationship between bowel bacteria and immune complexes. Treating the blind loop with antibiotics and sphincteroplasty to prevent bacterial reflux into the blind loop helped 5 of 10 and 6 of 9 patients, respectively. A comparison is made to other bowel associated arthritides.
PMID: 7236324, UI: 81207373
Other Formats: [Citation Format] [MEDLINE Format]
Links: [120 medline neighbors]
Order this document
J Am Acad Dermatol 1980 Jun;2(6):488-95

Systemic immune complex disease following intestinal bypass surgery: bypass disease.

Utsinger PD

Twenty-one patients with arthritis and dermatitis following intestinal bypass surgery were studied. The arthritis was polyarticular, remittent, and intermittent. Typically, the synovial fluid was inflammatory. The commonest inflammatory skin lesion was a vesiculopustular dermatitis. Nineteen patients and serum immmune complexes using the Raji cell technic. Seventeen patients had serum cryoproteins, primarily consisting of IgG 1, IgG 3, C3, and C4. Three patients had both Escherichia coli antigens and anti-E. coli antibody in their cryoprotein. Five patients had granular and one had linear deposits of immunoglobulin and complement at the dermoepidermal junction. Further evidence that bacterial antigens play a role in tissue injury was provided by detection of granular deposits of E. coli antigen at the dermoepidermal junctions in two patients, and at the glomerular capillary basement membrane in one patient.
PMID: 6447168, UI: 80250045
Other Formats: [Citation Format] [MEDLINE Format]
Links: [100 medline neighbors]
Order this document
Hosp Pract 1977 Jan;12(1):73-82

Ileal bypass for obesity: postoperative perspective.

Faloon WW

Initially, diarrhea is almost universal but becomes self-limited unless the patient persists in overeating. Weight loss averages 75 to 100 lb the first year, with a stable level generally achieved after 18 months. Among the serious potential complications are enteritis, kidney stones, gallstones, and hepatopathology. Some can be anticipated and kept at bay by prophylactic measures like high-protein intake.
PMID: 838488, UI: 77117544
Other Formats: [Citation Format] [MEDLINE Format]
Links: [108 medline neighbors]
Order this document
Am J Clin Nutr 1977 Jan;30(1):76-89

Bypass enteropathy: an inflammatory process in the excluded segment with systemic complications.

Drenick EJ, Ament ME, Finegold SM, Passaro E Jr

Evidence is presented that many of the enteric and systemic manifestations after jejunoileal bypass can be related to an inflammatory process within the bypassed small bowel rather than to the surgically induced sequelae of a short bowel syndrome with malabsorption. Invasion of the excluded segment by fecal flora was associated with a histologically demonstrable inflammatory response of the mucosa. The disorder was of variable severity and duration and occurred in the majority of 28 bypass patients. Progression to a clinical syndrome resembling an acute abdomen occurred in about 15% of the patients. Small bowel ileus and, in some patients, obstruction of the colon were suggested by physical signs and x-ray findings. Surgical exploration in such instances demonstrated an inflammaotry process of the excluded small bowel loops with severe distention of this segment and of the colon, but not organic obstruction. Pneumatosis cystoides intestinalis was a sequal in two patients. Exudative protein loss was documented in the severe cases. Most of the systemic sequelae are comparable to those seen with inflammatory diseases of the bowel such as Crohn's disease. Fever, excessive weight and lean tissue loss, and the involvement of skin, blood vessels, joints and possibly, the liver suggest an immune response as a common factor in the pathogenesis. The clinical improvement with antibiotics such as metronidazole or with restitution of normal bowel continuity indicates that the bacterial flora in the excluded small bowel segment or its byproducts are causally related to the systemic complications. Hyperoxaluria may be primarily the sequela of steatorrhea and not of the inflammatory process.
PMID: 831442, UI: 77084961
the above reports in format
documents on this page through Loansome Doc

 

 

Home Up Patient Emails Search Contents Contact Us Compare MGB
This notice describes how information about you may be used and disclosed and how you can gain access to this information.  Please review carefully


Contact Information: -Telephones: *** CLOS West: 702-456-4643; Trish Lanman 702-376-3446, Sandy Brubaker 702-376-3647; Jennifer Brubaker 702-376-9339, Dr. Rutledge 702-215-9550; 989-450-8081 Kim Hazen 989-450-8081 *** CLOS Florida: Flo Ballengee 863-899-3463 Wayne Robbins 704-682-1549 Elizabeth Robbins 704-928-6693 Dr. Cesare Peraglie 407-922-3424


Email Us Anytime for Help:
Email: Dr. Rutledge DrR@clos.net, *** CLOS West: Trish Lanman Trish@clos.net, Sandy Brubaker SandyB@clos.net Dr. Rutledge DrR@clos.net, Kim Hazen khazen@clos.net *** CLOS Florida: Flo Ballengee flo@clos.net, Wayne Robbins wr@clos.net Elizabeth Robbins epr@clos.net Dr. Peraglie drp@clos.net


Addresses:
Address: *** CLOS West Office: Dr Robert Rutledge / CELOS, 98 E Lake Mead Parkway Suite 302, Henderson NV 89015, Office 702-456-4643, Office fax: 702-456-1173, Contacts: Trish Lanman 702-376-3446 Trish@clos.net, Sandy Brubaker 702-376-3647 SandyB@clos.net, Jennifer Brubaker 702-376-9339 Jen@clos.net, Dr. Rutledge 702-215-9550 Drr@clos.net Kim Hazen 989-450-8081 khazen@clos.net *** CLOS Florida: 40124 Highway 27, Suite 203, Davenport, FL 33837, Wayne Robbins 704-682-1549, wr@clos.net, Elizabeth Robbins 704-928-6693 epr@clos.net, Dr. Peraglie 407-922-3424 drp@clos.net


Warning: Gastric Bypass Surgery is a MAJOR surgical procedure. It can be associated with significant risks and complications, up to and including death. Weight loss surgery is a rapidly developing area of medicine. Bariatric surgery is filled with controversy. It is very important to take a careful and deliberate approach to considering surgery for the treatment of obesity.  

Disclaimer Notice:-Information on this web site is provided for informational purposes only.
-It is imperative that you consult your own physician regarding the applicability of any opinions or recommendations with respect to your symptoms or medical condition.
-Contact with this web site or Dr. Rutledge over the web site does not constitute a doctor patient relationship and for good quality medical care you must obtain advice and consultation form your own local physician.
-This site is intended as a resource for references on the treatment of obesity for health care professionals and educated consumers.
-The authors and editors have used sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.
-Medical knowledge changes rapidly. In view of the possibility of human error or changes in medical science, neither the authors nor the editors nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.
This information is not medical advice or diagnosis, nor is it to be construed as medical advice, medical information, medical diagnosis, or medical prescription for curing, removing, or preventing any disease, or related symptoms. You must seek the direct assistance, advice and evaluation of your own personal physician before acting on any information found herein. These statements have not been evaluated by the Food and Drug Administration.
-Readers are Strongly encouraged to discuss and confirm the information contained herein with your own physician.
Copyright © 1998 The Center for Laparoscopic Obesity Surgery